The Trusted Endemic Health Platform

Smarter health decisions begin with DxCheck

The endemic health platform built for the moment of decision. We connect diagnosed patients, their caregivers and HCPs with trusted, AI-powered tools the moment they're searching for answers — turning high-intent signals into better outcomes for people, partners, and brands.

What sets DxCheck apart

Four foundational principles that make DxCheck the most defensible, credible, and high-performing endemic platform.

A “Church and State” model where non-generative AI handles clinical assessment with zero hallucination risk, while brand messaging stays quarantined to medically-reviewed environments — letting brands leverage AI engagement without MLR risk.

A structured clinical inquiry — modeled after a Physician Assistant consult — captures health history and produces rank-ordered diagnostic probabilities, directing patients to high-quality editorial brands can activate against.

Condition-verified audiences engaged across awareness, decision, and adherence phases consistently outperform industry benchmarks — delivering 13.1x targeting multiples, 5x session durations, and CRM lead generation at scale.

NPI-verified clinicians peer-review every piece of content, and every editorial claim is supported by traceable, clinical-grade citations. Brand placements run only within this validated environment — full source transparency, zero UGC or AI hallucination risk.

Why partners choose us

The DxCheck Difference

Four foundational pillars that make DxCheck the most trusted, performant, and insight-rich endemic platform for DTC pharmaceutical brands.

01

Condition-verified audiences

Engage precision-targeted, diagnosed patients and caregivers through our exclusive platform — and extend reach to our zero and first party audiences programmatically.

02

Privacy-by-design framework

HIPAA-compliant environment ensuring trust, anonymity, and brand safety across all digital interactions.

03

Actionable insights & feedback

Capture real-time data on user behavior, sentiment, and symptom severity to drive informed strategy.

04

Measurable quantitative performance

Industry-leading attribution and audience metrics to quantify the impact of your DTC activations.

By the Numbers

Performance that outpaces the industry

Real engagement, real intent, real outcomes — benchmarked against industry standards across every campaign we run.

0+min

Average time on site

8x industry benchmark
0.00%

Click-through rate

5x industry benchmark
0.0x

Crossix Targeting Multiple

Crossix top performer
Audience Growth

DxCheck User Growth

Unique users from 2023 through 2026 — fueled by demand for credible, consumer-facing digital health tools.

Unique Users (2023–2026)

Hover over any bar to see annual figures

Unique users Growth trajectory
DxCheck unique users from 2023 to 2026 0 1.25M 2.5M 3.75M 5M 2023 (Launch) 2024 2025 2026 (Projected)
5x

Year-over-year growth from 2024 to 2025

90%+

Of users engage with our AI-powered assessments and symptom checkers

Our Partners

Trusted by leading brands

Pharmaceutical brands and agencies partner with DxCheck to reach diagnosed patients and caregivers at the moment of decision.

Acadia
argenx
AstraZeneca
Avalere Health
CMI
Collegium Pharmaceuticals
Gilead
GSK
Haleon
Havas
Healix
Horizon Media
Initiative
Invivyd
Eli Lilly
Lundbeck
Publicis Commerce
Real Chemistry
Regeneron
Sanofi
Soleno Therapeutics
Solve(d)
Sumitomo Pharma
Sunovion
Let's Talk

Get in touch

Interested in partnering with DxCheck or learning more about our platform? Tell us a bit about your goals and we'll get back to you within one business day.

  • Explore brand and partnership opportunities
  • Schedule a capabilities meeting with our team
  • Request audience insights for a specific condition
  • Get media kits, case studies, or pricing

Send us a message

All fields required unless marked optional.

We respect your inbox — your details stay with our BD team only.